Red ListRecovering

NAMSNewAmsterdam Pharma Company N.V

Healthcare · Biotechnology · mid-cap ($3.1B)
-34.2%
from rolling 252-day high of $42.21 set 2026-05-11 · 101d ago
Current
$27.81
Decline depth
-34.2%
Decline σ
4.6σ
TFC
1/5 bearish
Rolling 252-day high Up day Down day Last 90 trading days · data from Alpaca

Since it joined the list

$NAMS landed on the list 2026-03-03, down 27.6% from its 52-week high that day — now down -34.2%.

That's 6.0 percentage points deeper than the day it joined.

Decline from the 52-week high as it stood on 2026-03-03 (fixed anchor) → today. Split-adjusted, Alpaca. Observed history, not a forecast.

Structural break signals

NAMS qualifies for the Red List on decline depth.

Decline depth
-34.2%
From rolling 252-day high of $42.21, 101d ago. Past the 30% Amber threshold.
Time-frame continuity
1/5 bearish
Latest bar across daily/weekly/monthly/quarterly/yearly time frames. A bar counts as bearish when it's a 2-Down or a red 3.
Decline sigma
4.6σ
Drop from local high over the last 20 bars, expressed in units of the stock's typical daily volatility (2.59% per day). Past the ≥4σ Watch threshold.

The structural read

What price action says about NAMS.

NAMS qualifies for the Red List on decline depth — down -34.2% from its rolling 252-day high. Past 30% with the high set inside the last four months — the recency clause that often precedes further breakdown. Depth plus recency: this is the pattern many investors call a falling knife.

Cross-confirmation: decline sigma also reads 4.6σ over 20 bars.

Alongside that decline, our proprietary engine has flagged a confirmed bullish structural signal on one or more time frames — moderate or strong time-frame-continuity (TFC) alignment — so the ticker also carries a Recovering badge. The two readings coexist: the tier tells you how deep the damage is, the Recovering badge tells you whether momentum may be turning. Recovering is not a buy signal; it's a structural read.

Broken Stocks stops here — it flags the structure, it doesn't build the upside case. Working out whether NAMS's turn is investable is what our sister tool does: ConvictionEdge — triple-engine conviction research on names showing a recovery signal.

Upstream TFC read: moderate alignment, current phase daily. Last bar types — daily 2D (red), weekly 1 (green), monthly 2D (green).

Earnings on file: 2026-08-05. Tiering is unaffected by earnings dates — listings reflect price structure only.

Questions about NAMS

What people ask.

Why is NAMS on Broken Stocks?

NAMS qualifies for the Red List on decline depth. It is down -34.2% from its rolling 252-day high of $42.21, set on 2026-05-11 — 101d ago. It additionally carries a Recovering badge — see below.

What does the Recovering badge mean for NAMS?

Recovering means our proprietary engine has flagged a confirmed bullish structural signal on one or more time frames (moderate or strong time-frame continuity). It coexists with the decline tier — NAMS is still Red List because the rolling-252-day decline hasn't healed, but a bullish setup has formed inside that decline. The two readings answer different questions: the tier tells you how deep the damage is; the Recovering badge tells you whether momentum may be turning. It's not a buy recommendation.

Is NAMS a falling knife?

By the most common technical definition — a steep, recent breakdown from a fresh high — yes. NAMS is down -34.2% from its 52-week high of $42.21, set 101d ago. That combination of depth (past the 30% Amber threshold) and recency (high set inside the last 120 days) is the textbook falling-knife pattern. Whether to try to catch it is a separate question — historically most attempts to bottom-pick continue lower before reversing. Broken Stocks flags the pattern; it does not recommend buying or selling.

Is NAMS a buy?

Broken Stocks does not issue buy or sell recommendations. The list is a rules-based technical warning system. It tracks structural decline depth and recency — not company quality, management, fundamentals, or news. Always do your own research and consult a licensed advisor.

Where is NAMS trading inside its 52-week range?

At $27.81, NAMS sits 24.8% of the way from its 52-week low ($23.05) to its 52-week high ($42.20). A reading below 25% indicates price is hugging the bottom of the range; above 75%, the top.

How fast has NAMS been declining?

The current 34.2% decline accrued over 101d, which annualizes to roughly -123.6% per year. Annualized pace is a sanity check — a 30% decline in three months is a different signal than a 30% decline over two years.

How does NAMS compare to its sector?

There are 143 other Healthcare tickers on Broken Stocks: 69 Red, 35 Amber, 39 Watch, with 49 showing recovering structural signals. Median sector decline is -36.1% — NAMS's decline is shallower than the sector median.

Does NAMS's earnings date affect its tier?

No. Tiering is decided purely by decline depth and recency of the rolling-high date. The earnings date on file (2026-08-05) is shown for reference only — listings can move tier between scans based on closing prices, regardless of fundamentals or news events.